Improving equine health: Research studies vaccinations to protect newborn foals

A Kansas State University veterinary medicine student is investigating ways to improve horse vaccinations and defend them against pathogen challenges at an early age.

Research from Allison Jordan Bryan, a graduate student in and a second-year student, Huntington Beach, Calif., may help protect foals as young as 3 months of age from pathogens such as , tetanus, equine influenza virus, Equine Herpes Virus-1, Eastern equine encephalomyelitis and Western equine encephalomyelitis.

"It is important, especially in the equine world, to vaccinate the foals as soon as possible so they will be protected against environmental pathogens they may come into contact with, even at an early age," Bryan said.

Bryan recently received a second place award at the K-State Research Forum for her oral research presentation titled "Characterization of in healthy foals when vaccination is initiated at 3 months of age."

Foals acquire maternal antibodies and that help protect them from environmental pathogens before they can fully develop their own immune systems, Bryan said. Newborn foals acquire these maternal antibodies and cells through ingestion and absorption of colostrum.

Foals are usually vaccinated at 6 months of age, which gives time for maternal antibodies to decline so they do not interfere with any vaccines. But Bryan is looking at the possibility of vaccinating foals at 3 months of age -- the earlier age is better because it gives foals more protection against pathogens earlier in life.

"We're trying to determine whether those are still in high enough concentration at 3 months to interfere with vaccines and block the active immune response or to see if these antibodies have waned enough to allow a robust immune response," Bryan said.

Bryan is still collecting and analyzing data. Preliminary data has indicated an in 3-month-old foals, making it possible to vaccinate foals at a younger age and increase protection.

Although Bryan has always been interested in the , she got involved with equine research after spending a summer in the university's Veterinary Research Scholars Program, which is funded by the National Institutes of Health, or NIH, and Merial, a worldwide animal health company.

Bryan is now participating in the NIH-funded Basic Research Immersion Training Experience, or BRITE, program. Her faculty advisers are Elizabeth Davis, associate professor of clinical sciences, and Melinda Wilkerson, professor of diagnostic medicine and pathobiology.

"Jordan is a talented individual who has a very bright future in the field of biomedical research," Davis said. "In the past year she has gained knowledge and skills that will help her with her future investigative endeavors. It has been a pleasure to have her as a graduate student in our program."

"The mentorship and guidance has made it a wonderful experience and I will definitely pursue a career in research following completion of my veterinary degree," Bryan said. "I have been very fortunate to work with extremely talented individuals at K-State and am honored to be a part of the research community here at K-State."

add to favorites email to friend print save as pdf

Related Stories

The short goodbye: Weaning foals

Oct 06, 2011

It is widely believed that being born is about the most stressful thing that can happen to anybody. But being weaned cannot be too far behind it in the list of traumatic experiences. Most humans come to terms with it eventually ...

The mark of the beast: tradition or stress?

Sep 28, 2011

For animal welfare reasons, many veterinarians are currently promoting the method of implanting a microchip over the traditional practice of branding. However, officials of major sport horse breed registries deny that branding ...

Treating newborn horses: A unique form of pediatrics

Apr 06, 2011

Like any other newborn, the neonatal horse can be a challenging patient. Its immune system is still under construction, its blood chemistry can vary wildly, and – like most infants – it wants to ...

Recommended for you

New hope for rare disease drug development

8 hours ago

Using combinations of well-known approved drugs has for the first time been shown to be potentially safe in treating a rare disease, according to the results of a clinical trial published in the open access Orphanet Journal of ...

Three weeks since last Ebola case in Mali: WHO

11 hours ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

Migraine may double risk for facial paralysis

12 hours ago

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology, the medical journa ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.